1. Home
  2. ALMS vs TMCI Comparison

ALMS vs TMCI Comparison

Compare ALMS & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALMS
  • TMCI
  • Stock Information
  • Founded
  • ALMS 2021
  • TMCI 2014
  • Country
  • ALMS United States
  • TMCI United States
  • Employees
  • ALMS N/A
  • TMCI N/A
  • Industry
  • ALMS
  • TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • ALMS
  • TMCI Health Care
  • Exchange
  • ALMS NYSE
  • TMCI Nasdaq
  • Market Cap
  • ALMS 402.6M
  • TMCI 371.1M
  • IPO Year
  • ALMS 2024
  • TMCI 2021
  • Fundamental
  • Price
  • ALMS $2.86
  • TMCI $5.53
  • Analyst Decision
  • ALMS Strong Buy
  • TMCI Hold
  • Analyst Count
  • ALMS 7
  • TMCI 6
  • Target Price
  • ALMS $24.50
  • TMCI $9.18
  • AVG Volume (30 Days)
  • ALMS 1.1M
  • TMCI 352.4K
  • Earning Date
  • ALMS 08-12-2025
  • TMCI 08-05-2025
  • Dividend Yield
  • ALMS N/A
  • TMCI N/A
  • EPS Growth
  • ALMS N/A
  • TMCI N/A
  • EPS
  • ALMS N/A
  • TMCI N/A
  • Revenue
  • ALMS $17,389,000.00
  • TMCI $210,819,000.00
  • Revenue This Year
  • ALMS N/A
  • TMCI $10.61
  • Revenue Next Year
  • ALMS N/A
  • TMCI $10.36
  • P/E Ratio
  • ALMS N/A
  • TMCI N/A
  • Revenue Growth
  • ALMS N/A
  • TMCI 7.54
  • 52 Week Low
  • ALMS $2.81
  • TMCI $4.54
  • 52 Week High
  • ALMS $13.53
  • TMCI $10.79
  • Technical
  • Relative Strength Index (RSI)
  • ALMS N/A
  • TMCI 34.86
  • Support Level
  • ALMS N/A
  • TMCI $5.36
  • Resistance Level
  • ALMS N/A
  • TMCI $6.28
  • Average True Range (ATR)
  • ALMS 0.00
  • TMCI 0.24
  • MACD
  • ALMS 0.00
  • TMCI -0.00
  • Stochastic Oscillator
  • ALMS 0.00
  • TMCI 16.30

About ALMS ALUMIS INC

Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. Company pipeline includes: ESK-001, TYK2, A-OO5, IRF5.

About TMCI Treace Medical Concepts Inc.

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.

Share on Social Networks: